The recent SA article mentioned a comparable MC to IMUC, or 152MM MC. A valuation of 150MM MC here is around $30 PPS. It wasn't so long ago that SA reiterated at 0.50 pre-r/s PPS target (jan 2012) which I think equates to north of $60PPS. And that was w/o an ODD (and two other apps under consideration).
SA may have to rethink/re-peg the current $7.5 PPS target, given the comps in the neighborhood of 100-150MM MC recently mentioned. A double-digit target PPS woudln't be a surprise.
I'd like to see material news for a partnership/uplist,to a major exchange, and if the science prevails and makes it's mark in immunotherpy, exposure to the masses amid a limited number of OS would be very interesting indeed.
We need to get back over $5 where the r/s took place. Hopefully then we can get on a better exchange and attract more investors. However, positive results for the trials will ultimately drive the stock much higher
Our mkt cap is ridiculously low at this pooint